|
|
Research OverviewLed by Professor Shirley (Xiao Yu) Wu, our research is centered on advanced pharmaceutics and drug delivery technologies. The goal of our research is to develop novel drug delivery strategies and systems to enhance treatment of major diseases such as cancer & diabetes.
Innovative approaches have been undertaken to achieve this goal by integrating multidisciplinary techniques and knowledge including micro- and nanotechnology, chemistry, computer simulation, engineering, pharmaceutics, pharmacology, and oncology. Our research program is highly interdisciplinary which bridges bio-sciences, materials sciences, physical sciences with clinical applications.
Recent NewsWe would like to thank our past and present funders and partners:
|
Recent Publications
Yen T.Y., Abbasi A.Z., He C., Lip H.Y., Park E., Amini M.A., Adissu H.A., Foltz W., Rauth A.M., Henderson J., Wu X.Y., 2024. Biocompatible and bioactivable terpolymer-lipid-MnO2 Nanoparticle-based MRI contrast agent for improving tumor detection and delineation. Materials Today Bio. https://doi.org/10.1016/j.mtbio.2024.100954 
Zetrini, A. E., Lip, H., Abbasi, A. Z., Alradwan, I., Ahmed, T., He, C., Henderson, J. T., Rauth, A. M., & Wu, X. Y., 2023. Remodeling tumor immune microenvironment by using polymer-lipid-manganese dioxide nanoparticles with radiation therapy to boost immune response of castration-resistant prostate cancer. Research.
Park, E., Li, L.Y., He, C., Abbasi, A.Z., Ahmed, T., Foltz, W.D., O'Flaherty, R., Zain, M., Bonin, R.P., Rauth, A.M., Fraser, P.E., Henderson, J.T., Wu, X.Y., 2023. Brain‐penetrating and disease site‐targeting manganese dioxide‐polymer‐lipid hybrid nanoparticles remodel microenvironment of alzheimer's disease by regulating multiple pathological pathways. Advanced Science.
|
